In this study, all 11 children with primary FSGS and post-transplant recurrence demonstrated significantly higher levels of circulating anti-nephrin antibodies, compared to subjects with primary FSGS who did not recur, genetic FSGS, and healthy/disease controls. The gene discussed is NPHS1; the disease is focal segmental glomerulosclerosis.